EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $471,109 | -28.9% | 24,234 | +3.8% | 0.04% | -2.5% |
| Q1 2023 | $662,638 | +14.7% | 23,357 | +18.1% | 0.04% | +5.3% |
| Q4 2022 | $577,965 | -29.5% | 19,773 | -36.3% | 0.04% | -29.6% |
| Q3 2022 | $820,000 | -14.4% | 31,025 | +43.9% | 0.05% | +5.9% |
| Q2 2022 | $958,000 | +18.6% | 21,554 | +32.0% | 0.05% | +21.4% |
| Q1 2022 | $808,000 | +56.6% | 16,330 | +61.2% | 0.04% | +35.5% |
| Q4 2021 | $516,000 | -54.9% | 10,132 | -50.6% | 0.03% | -51.6% |
| Q3 2021 | $1,143,000 | +9.2% | 20,492 | -16.2% | 0.06% | +14.3% |
| Q2 2021 | $1,047,000 | -6.5% | 24,460 | -8.9% | 0.06% | -12.5% |
| Q1 2021 | $1,120,000 | +41.2% | 26,837 | +57.6% | 0.06% | +12.3% |
| Q4 2020 | $793,000 | -36.6% | 17,032 | -42.2% | 0.06% | +39.0% |
| Q3 2020 | $1,251,000 | -77.9% | 29,444 | -75.0% | 0.04% | -71.9% |
| Q2 2020 | $5,649,000 | -13.1% | 117,743 | -16.7% | 0.15% | -15.1% |
| Q1 2020 | $6,503,000 | -29.8% | 141,371 | -8.3% | 0.17% | +32.3% |
| Q4 2019 | $9,266,000 | +2466.8% | 154,224 | +2318.8% | 0.13% | +3150.0% |
| Q3 2019 | $361,000 | +15.0% | 6,376 | +12.9% | 0.00% | -33.3% |
| Q2 2019 | $314,000 | -96.7% | 5,646 | -97.6% | 0.01% | -97.1% |
| Q4 2018 | $9,552,000 | – | 237,080 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |